# BDMD (Baird Medical Investment Holdings Limited) - SEC EDGAR Financial Statements

> Baird Medical Investment Holdings Limited reported $22.54M in revenue and a net loss of $27.28M for the fiscal year ended December 31, 2025 (down 39.2% year over year), with a 83.8% gross margin and a -113.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/BDMD
- Markdown: https://convexityos.com/fundamentals/BDMD.md
- SEC CIK: 0001982444
- Reporting currency: USD
- Latest filing period: December 31, 2025
- Last synced: Nov 21, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001982444&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $22.54M | -39.2% YoY |
| Operating Income | FY 2025 | -$25.63M | -113.7% margin |
| Net Income | FY 2025 | -$27.28M | -121.0% net margin |
| Diluted EPS | FY 2025 | -$0.98 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$1.39M | -6.2% FCF margin |
| Cash & ST Investments | Dec 31, 2025 | $178K | Total debt: $8.87M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | $22.54M | $37.04M | $31.46M | $35.09M |
| Cost of Revenue | $3.65M | $4.38M | $4.23M | $7.05M |
| **Gross Profit** | $18.88M | $32.65M | $27.23M | $28.04M |
| Research & Development | $20.13M | $6.17M | $4.27M | $3.86M |
| Selling, General & Admin | $24.38M | $11.16M | $11.09M | $10.55M |
| Total Operating Expenses | $44.51M | $17.34M | $15.37M | $14.41M |
| **Operating Income** | -$25.63M | $15.32M | $11.86M | $13.63M |
| **EBITDA** | -$24.53M | $16.45M | $12.88M | $14.55M |
| Interest Income | -- | $393 | $1.6K | $8.6K |
| Interest Expense | $737K | $576K | $284K | $299K |
| Income Before Tax | -$26.37M | $14.09M | $12.36M | $14.52M |
| Income Tax Expense | $1.17M | $1.49M | $1.70M | $1.75M |
| **Net Income** | -$27.28M | $12.45M | $10.55M | $12.57M |
| Basic EPS | -$0.98 | $0.57 | $0.51 | $0.49 |
| **Diluted EPS** | -$0.98 | $0.57 | $0.51 | $0.49 |
| Basic Shares Outstanding | 27.8M | 21.8M | 20.6M | 25.6M |
| Diluted Shares Outstanding | 27.8M | 21.8M | 20.6M | 25.6M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $178K | $2.97M | $1.51M |
| **Cash & Short-Term Investments** | $178K | $2.97M | $1.51M |
| Accounts Receivable, Net | $42.53M | $46.58M | $31.10M |
| Inventory | $1.09M | $1.30M | $1.14M |
| **Total Current Assets** | $54.97M | $61.42M | $40.08M |
| Property, Plant & Equipment, Net | $6.37M | $7.14M | $6.14M |
| Goodwill | $60K | $58K | $59K |
| Intangible Assets | $8.6K | $17K | $25K |
| **Total Non-Current Assets** | $14.73M | $16.55M | $16.63M |
| **Total Assets** | $69.70M | $77.96M | $56.71M |
| Accounts Payable | $1.81M | $1.25M | $550K |
| Short-Term Debt | $2.64M | $868K | $817K |
| Deferred Revenue (Current) | $793K | $792K | $500K |
| Other Current Liabilities | $4.89M | $3.70M | $3.79M |
| **Total Current Liabilities** | $32.36M | $34.62M | $18.98M |
| Long-Term Debt | $6.09M | $3.44M | $1.61M |
| **Total Non-Current Liabilities** | $6.11M | $3.58M | $2.03M |
| **Total Liabilities** | $38.48M | $38.20M | $21.00M |
| **Total Debt (incl. Leases)** | $8.87M | $4.71M | $3.33M |
| Common Stock | $3.1K | $2.6K | $2.6K |
| Retained Earnings | -$515K | $26.76M | $14.39M |
| Accumulated Other Comp. Income | -$1.37M | -$3.14M | -$2.01M |
| **Total Stockholders' Equity** | $31.37M | $39.66M | $35.75M |
| Total Equity | $31.22M | $39.76M | $35.71M |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $178K | $2.97M | $1.51M |
| **Cash & Short-Term Investments** | $178K | $2.97M | $1.51M |
| Accounts Receivable, Net | $42.53M | $46.58M | $31.10M |
| Inventory | $1.09M | $1.30M | $1.14M |
| **Total Current Assets** | $54.97M | $61.42M | $40.08M |
| Property, Plant & Equipment, Net | $6.37M | $7.14M | $6.14M |
| Goodwill | $60K | $58K | $59K |
| Intangible Assets | $8.6K | $17K | $25K |
| **Total Non-Current Assets** | $14.73M | $16.55M | $16.63M |
| **Total Assets** | $69.70M | $77.96M | $56.71M |
| Accounts Payable | $1.81M | $1.25M | $550K |
| Short-Term Debt | $2.64M | $868K | $817K |
| Deferred Revenue (Current) | $793K | $792K | $500K |
| Other Current Liabilities | $4.89M | $3.70M | $3.79M |
| **Total Current Liabilities** | $32.36M | $34.62M | $18.98M |
| Long-Term Debt | $6.09M | $3.44M | $1.61M |
| **Total Non-Current Liabilities** | $6.11M | $3.58M | $2.03M |
| **Total Liabilities** | $38.48M | $38.20M | $21.00M |
| **Total Debt (incl. Leases)** | $8.87M | $4.71M | $3.33M |
| Common Stock | $3.1K | $2.6K | $2.6K |
| Retained Earnings | -$515K | $26.76M | $14.39M |
| Accumulated Other Comp. Income | -$1.37M | -$3.14M | -$2.01M |
| **Total Stockholders' Equity** | $31.37M | $39.66M | $35.75M |
| Total Equity | $31.22M | $39.76M | $35.71M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$27.54M | $12.60M | $10.66M | $12.77M |
| Depreciation & Amortization | $1.10M | $1.14M | $1.01M | $916K |
| Stock-Based Compensation | $17.47M | $0 | $0 | -- |
| Change in Receivables | $5.35M | -$17.80M | -$9.67M | -$14.84M |
| Change in Inventory | $260K | -$188K | $114K | $1.57M |
| Change in Payables | $484K | $728K | $342K | -$101K |
| **Operating Cash Flow** | -$1.34M | -$6.31M | -$1.02M | $486K |
| Capital Expenditure | -$42K | -$2.85M | -$2.64M | -$5.91M |
| **Free Cash Flow** | -$1.39M | -$9.17M | -$3.66M | -$5.42M |
| **Investing Cash Flow** | -$42K | -$2.47M | -$2.65M | -$5.92M |
| **Financing Cash Flow** | -$1.39M | $10.33M | $3.48M | $4.41M |
| **Net Change in Cash** | -$2.40M | $1.46M | -$200K | -$1.32M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | 83.8% | 88.2% | 86.6% | 79.9% |
| **Operating Margin** | -113.7% | 41.4% | 37.7% | 38.8% |
| **Net Profit Margin** | -121.0% | 33.6% | 33.5% | 35.8% |
| Return on Equity (ROE) | -87.0% | 31.4% | 29.5% | -- |
| Return on Assets (ROA) | -39.1% | 16.0% | 18.6% | -- |
| Current Ratio | 1.70x | 1.77x | 2.11x | -- |
| Quick Ratio | 1.66x | 1.74x | 2.05x | -- |
| Debt to Equity | 0.28x | 0.12x | 0.09x | -- |
| **Revenue Growth (YoY)** | -39.2% | +17.7% | -10.4% | -- |
| Gross Profit Growth (YoY) | -42.2% | +19.9% | -2.9% | -- |
| Operating Income Growth (YoY) | -267.4% | +29.1% | -13.0% | -- |
| **Net Income Growth (YoY)** | -319.0% | +18.1% | -16.1% | -- |
| EPS Growth (YoY) | -271.9% | +11.8% | +4.1% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -309.9% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
